Identification of core functional region of murine IL-4 using peptide phage display and molecular modeling

International Immunology

Volumn 18, Issue 1, 2006, Pages 19-29

  Yao, Gang ^a   Chen, Weiyan ^b   Luo, Haibin ^c   Jiang, Qunfeng ^a   Xia, Zongxiang ^b   Zang, Lei ^a   Zuo, Jianping ^c   Wei, Xin ^d   Chen, Zhengjun ^a   Shen, Xu ^c   Dong, Chen ^e   Sun, Bing ^a,f  

^a INSTITUTE OF BIOCHEMISTRY AND CELL BIOLOGY   (China)

^b SHANGHAI INSTITUTE OF ORGANIC CHEMISTRY   (China)

^c SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

^d GL Biochem (Shanghai) Ltd   (China)

^e UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^f University of Shanghai   (China)

Author keywords

11B.11; Core functional region of IL 4; IL 4; Molecular modeling; Peptide phage display

Indexed keywords

AMINO ACID; INTERLEUKIN 4; INTERLEUKIN 4 ANTIBODY; INTERLEUKIN 4 RECEPTOR ALPHA; NEUTRALIZING ANTIBODY;

ANIMAL CELL; ARTICLE; BINDING SITE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOPRECIPITATION; MOLECULAR CLONING; MOLECULAR MODEL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHAGE DISPLAY; PLEIOTROPY; POLYMERASE CHAIN REACTION; PREDICTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN LOCALIZATION; RAT; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS; T LYMPHOCYTE;

AMINO ACID SUBSTITUTION; ANIMALS; ANTIBODIES, MONOCLONAL; BINDING SITES; EPITOPE MAPPING; INTERLEUKIN-4; MICE; MODELS, MOLECULAR; MOLECULAR CONFORMATION; MUTAGENESIS, SITE-DIRECTED; PEPTIDE LIBRARY; PROTEIN BINDING; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 30344465761     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxh338     Document Type: Article

References (56)

1. Keegan, A. D. and Paul, W. E. 1992. Multichain immune recognition receptors: Similarities in structure and signaling pathways. Immunol. Today 13:63.
2. Cheever, A. W., Williams, M. E., Wynn, T. A. et al. 1994. Anti-IL-4 treatment of Schistosoma mansoni-infected mice inhibits development of T cells and non-B, non-T cells expressing Th2 cytokines while decreasing egg-induced hepatic fibrosis. J. Immunol. 153:753.
3. Gessner, A., Schroppel, K., Will, A., Enssle, K. H., Lauffer, L. and Rollinghoff, M. 1994. Recombinant soluble interleukin-4 (IL-4) receptor acts as an antagonist of IL-4 in murine cutaneous leishmaniasis. Infect. Immun. 62:4112.
4. Kopf, M., Le Gros, G., Bachmann, M., Lamers, M. C., Bluethmann, H. and Kohler, G. 1993. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362:245.
5. Romani, L., Mencacci, A., Grohmann, U. et al. 1992. Neutralizing antibody to interleukin 4 induces systemic protection and T helper type 1-associated immunity in murine candidiasis. J. Exp. Med. 176:19.
6. Sadick, M. D., Heinzel, F. P., Holaday, B. J., Pu, R. T., Dawkins, R. S. and Locksley, R. M. 1990. Cure of murine leishmaniasis with anti-interleukin 4 monoclonal antibody. Evidence for a T cell-dependent, interferon gamma-independent mechanism. J. Exp. Med. 171:115.
7. Bogdan, C., Gessner, A., Solbach, W. and Rollinghoff, M. 1996. Invasion, control and persistence of Leishmania parasites. Curr. Opin. Immunol. 8:517.
8. Erb, K. J., Ruger, B., von Brevern, M., Ryffel, B., Schimpl, A. and Rivett, K. 1997. Constitutive expression of interleukin (IL)-4 in vivo causes autoimmune-type disorders in mice. J. Exp. Med. 185:329.
9. Biedermann, T., Zimmermann, S., Himmelrich, H. et al. 2001. IL-4 instructs TH1 responses and resistance to Leishmania major in susceptible BALB/c mice. Nat. Immunol. 2:1054.
10. Fort, M., Lesley, R., Davidson, N. et al. 2001. IL-4 exacerbates disease in a Th1 cell transfer model of colitis. J. Immunol. 166: 2793.
11. Paul, W. E. and Seder, R. A. 1994. Lymphocyte responses and cytokines. Cell 76:241.
12. Nelms, K., Keegan, A. D., Zamorano, J., Ryan, J. J. and Paul, W. E. 1999. The IL-4 receptor: Signaling mechanisms and biologic functions. Annu. Rev. Immunol. 17:701.
13. Murata, T., Obiri, N. I. and Puri, R. K. 1998. Structure of and signal transduction through interleukin-4 and interleukin-13 receptors (review). Int. J. Mol. Med. 1:551.
14. Matthews, D. J., Clark, P. A., Herbert, J. et al. 1995. Function of the interleukin-2 (IL-2) receptor gamma-chain in biologic responses of X-linked severe combined immunodeficient B cells to IL-2, IL-4, IL-13, and IL-15. Blood 85:38.
15. Matthews, D. J., Hibbert, L., Friedrich, K., Minty, A. and Callard, R. E. 1997. X-SCID B cell responses to interleukin-4 and interleukin-13 are mediated by a receptor complex that includes the interleukin-4 receptor alpha chain (p140) but not the gamma c chain. Eur. J. Immunol. 27:116.
16. Andersson, A., Grunewald, S. M., Duschl, A., Fischer, A. and DiSanto, J. P. 1997. Mouse macrophage development in the absence of the common gamma chain: Defining receptor complexes responsible for IL-4 and IL-13 signaling. Eur. J. Immunol. 27:1762.
17. Ohara, J. and Paul, W. E. 1985. Production of a monoclonal antibody to and molecular characterization of B-cell stimulatory factor-1. Nature 315:333.
18. Yoshino, S., Murata, Y. and Ohsawa, M. 1998. Successful induction of adjuvant arthritis in mice by treatment with a monoclonal antibody against IL-4. J. Immunol. 161:6904.
19. Sato, T. A., Widmer, M. B., Finkelman, F. D. et al. 1993. Recombinant soluble murine IL-4 receptor can inhibit or enhance IgE responses in vivo. J. Immunol. 150:2717.
20. Kruse, N., Shen, B. J., Arnold, S., Tony, H. P., Muller, T. and Sebald, W. 1993. Two distinct functional sites of human interleukin 4 are identified by variants impaired in either receptor binding or receptor activation. EMBO J. 12:5121.
21. Zhu, Z., Ming, Y. and Sun, B. 2001. Identification of epitopes of trichosanthin by phage peptide library. Biochem. Biophys. Res. Commun. 282:921.
22. Cai, X., Yao, G., Xu, G. et al. 2002. Identification of the amino acid residues in trichosanthin crucial for IgE response. Biochem. Biophys. Res. Commun. 297:510.
23. Luzzago, A., Felici, F., Tramontano, A., Pessi, A. and Cortese, R. 1993. Mimicking of discontinuous epitopes by phage-displayed peptides, I. Epitope mapping of human H ferritin using a phage library of constrained peptides. Gene 128:51.
24. Favre, N. and Erb, P. 1993. Use of the CTL44 cell line, a derivative of CTL/L cells, to identify and quantify mouse interleukin-4 by bioassay. J. Immunol. Methods 164:213.
25. Essono, S., Frobert, Y., Grassi, J., Creminon, C. and Boquet, D. 2003. A general method allowing the design of oligonucleotide primers to amplify the variable regions from immunoglobulin cDNA. J. Immunol. Methods 279:251.
26. Piccioli, P., Ruberti, F., Biocca, S. et al. 1991. Neuroantibodies: molecular cloning of a monoclonal antibody against substance P for expression in the central nervous system. Proc. Natl Acad. Sci. USA 88:5611.
27. Deleage, G., Clerc, F. F., Roux, B. and Gautheron, D. C. 1988. ANTHEPROT: A package for protein sequence analysis using a microcomputer. Comput. Appl. Biosci. 4:351.
28. Peitsch, M. C. 1996. ProMod and Swiss-Model: Internet-based tools for automated comparative protein modelling. Biochem. Soc. Trans. 24:274.
29. Guex, N. and Peitsch, M. C. 1997. SWISS-MODEL and the Swiss-PdbViewer: an environment for comparative protein modeling. Electrophoresis 18:2714.
30. Roussel, A. and Cambillau, C. 1991. TURBO-FRODO, Silicon Graphics Partner Geometry Dictionary, p. 86. Silicon Graphics Inc., Mountain View, CA.
31. Walter, M. R., Cook, W. J., Zhao, B. G. et al. 1992. Crystal structure of recombinant human interleukin-4. J. Biol. Chem. 267:20371.
32. Ito, S., Takayama, T., Hanzawa, H. et al. 2002. Crystal structure of the antigen-binding fragment of apoptosis-inducing mouse anti-human Fas monoclonal antibody HFE7A. J. Biochem. (Tokyo) 131:1373.
33. Mylvaganam, S. E., Paterson, Y. and Getzoff, E. D. 1998. Structural basis for the binding of an anti-cytochrome c antibody to its antigen: crystal structures of FabE8-cytochrome c complex to 1.8 A resolution and FabE8 to 2.26 A resolution. J. Mol. Biol. 281:301.
34. Brunger, A. T., Adams, P. D., Clore, G. M. et al. 1998. Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr. D Biol. Crystallogr. 54 (Pt 5):905.
35. He, T. C., Zhou, S., da Costa, L. T., Yu, J., Kinzler, K. W. and Vogelstein, B. 1998. A simplified system for generating recombinant adenoviruses. Proc. Natl Acad. Sci. USA 95:2509.
36. Greenlund, A. C., Farrar, M. A., Viviano, B. L. and Schreiber, R. D. 1994. Ligand-induced IFN gamma receptor tyrosine phosphorylation couples the receptor to its signal transduction system (p91). EMBO J 13:1591.
37. Sanchez de la Nieta, M. D., Sanchez-Fructuoso, A. I., Alcazar, R. et al. 2004. Higher graft salvage rate in renal allograft rupture associated with acute tubular necrosis. Transplant. Proc. 36:3016.
38. El-Zawahry, A., McKillop, J. and Voelkel-Johnson, C. 2005. Doxorubicin increases the effectiveness of Apo2L/TRAIL for tumor growth inhibition of prostate cancer xenografts. BMC Cancer 5:2.
39. Van Regenmortel, M. H. V. 1989. Structural and functional approaches to the study of protein antigenicity. Immunol. Today 10:265.
40. Myers, M. A., Davies, J. M., Tong, J. C. et al. 2000. Conformational epitopes on the diabetes autoantigen GAD65 identified by peptide phage display and molecular modeling. J. Immunol. 165:3830.
41. Nisihara, T., Ushio, Y., Higuchi, H. et al. 2001. Humanization and epitope mapping of neutralizing anti-human Fas ligand monoclonal antibodies: Structural insights into Fas/Fas ligand interaction. J. Immunol. 167:3266.
42. Ramanathan, L., Ingram, R., Sullivan, L. et al. 1993. Immunochemical mapping of domains in human interleukin 4 recognized by neutralizing monoclonal antibodies. Biochemistry 32:3549.
43. Chothia, C. 1976. The nature of the accessible and buried surfaces in proteins. J. Mol. Biol. 105:1.
44. Rose, G. D., Geselowitz, A. R., Lesser, G. J., Lee, R. H. and Zehfus, M. H. 1985. Hydrophobicity of amino acid residues in globular proteins. Science 229:834.
45. Bass, S. H., Mulkerrin, M. G. and Wells, J. A. 1991. A systematic mutational analysis of hormone-binding determinants in the human growth hormone receptor. Proc. Natl Acad. Sci. USA 88:4498.
46. Cunningham, B. C. and Wells, J. A. 1989. High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis. Science 244:1081.
47. Hage, T., Sebald, W. and Reinemer, P. 1999. Crystal structure of the interleukin-4/receptor alpha chain complex reveals a mosaic binding interface. Cell 97:271.
48. Duschl, A., Muller, T. and Sebald, W. 1995. Antagonistic mutant proteins of interleukin-4. Behring Inst. Mitt. 96:87.
49. Kruse, N., Tony, H. P. and Sebald, W. 1992. Conversion of human interleukin-4 into a high affinity antagonist by a single amino acid replacement. EMBO J. 11:3237.
50. Morrison, B. W. and Leder, P. 1992. A receptor binding domain of mouse interleukin-4 defined by a solid-phase binding assay and in vitro mutagenesis. J. Biol. Chem. 267:11957.
51. Grunewald, S. M., Kunzmann, S., Schnarr, B., Ezernieks, J., Sebald, W. and Duschl, A. 1997. A murine interleukin-4 antagonistic mutant protein completely inhibits interleukin-4-induced cell proliferation, differentiation, and signal transduction. J. Biol. Chem. 272:1480.
52. Grunewald, S. M., Werthmann, A., Schnarr, B. et al. 1998. An antagonistic IL-4 mutant prevents type I allergy in the mouse: inhibition of the IL-4/IL-13 receptor system completely abrogates humoral immune response to allergen and development of allergic symptoms in vivo. J. Immunol. 160:4004.
53. Schnare, M., Blum, H., Juttner, S., Rollinghoff, M. and Gessner, A. 1998. Specific antagonism of type I IL-4 receptor with a mutated form of murine IL-4. J. Immunol. 161:3484.
54. Tomkinson, A., Duez, C., Cieslewicz, G. et al. 2001. A murine IL-4 receptor antagonist that inhibits IL-4- and IL-13-induced responses prevents antigen-induced airway eosinophilia and airway hyperresponsiveness. J. Immunol. 166:5792.
55. Domingues, H., Cregut, D., Sebald, W., Oschkinat, H. and Serrano, L. 1999. Rational design of a GCN4-derived mimetic of interleukin-4. Nat. Struct. Biol. 6:652.
56. Kabat, E. A. and Wu, T. T. 1991. Identical V region amino acid sequences and segments of sequences in antibodies of different specificities. Relative contributions of VH and VL genes, mini-genes, and complementarity-determining regions to binding of antibody-combining sites. J. Immunol. 147:1709.